A stem cell IV infusion delivers a cell preparation into a vein. The IV route alone says nothing about whether the treatment works for a particular condition. A useful assessment starts with the product name, cell source, diagnosis and evidence behind the proposed use.
On this page
IV infusion, local injection and transplantation
These terms describe different aspects of treatment. IV identifies the delivery route; local injection places a preparation at a specified site. Haematopoietic stem cell transplantation is a distinct treatment programme used for selected diseases. The fact that cells can be given through a vein does not make these approaches equivalent.
Ask whether the proposal involves mesenchymal stromal cells, blood-forming cells or another preparation. Our HSCT versus MSC infusion guide explains the distinction. The ISSCR patient guide also explains why evidence must match the treatment and condition. ISSCR: guide to stem cell treatments.
What evidence and approvals mean
There are specific approved cell medicines. In the United States, Ryoncil is approved for steroid-refractory acute graft-versus-host disease in children aged two months and older. That narrowly defined approval does not establish benefit for general rejuvenation, joint disease or other uses, and does not determine regulatory status in Thailand. FDA: Ryoncil product information.
For any proposed infusion, request the study and ask how closely its participants, product and outcomes match your situation. A change in a laboratory marker is not automatically a meaningful improvement in symptoms or daily function. Testimonials cannot answer whether a treatment caused a reported improvement.
Before an infusion is considered
Prepare your diagnosis, recent clinical reports, current medicines, allergies and details of previous reactions to medicines or infusions. The clinician should explain whether additional assessment is needed and why. A generic package should not replace an individual review.
- What is the product, manufacturer and cell source?
- What testing is used to release the batch for treatment?
- What evidence supports this route for my diagnosis?
- Who monitors me during and after the infusion?
- What are the alternatives, including continuing usual care?
Ask for a written plan explaining observation, follow-up and what would lead the clinician to postpone or stop treatment.
Risks and monitoring
Possible concerns include infusion reactions, infection or contamination, and unwanted immune responses. Risks vary with the cells, preparation and patient. The FDA has received reports of serious harm involving unapproved regenerative products; its guidance should not be read as a risk estimate for every cell medicine. FDA: information about regenerative medicine therapies.
Ask how the facility recognises and treats an acute reaction and where emergency transfer would occur. During an infusion, report any new symptoms immediately. Breathing difficulty, chest pain, fainting or facial swelling requires immediate medical attention. Do not wait for a routine WhatsApp reply.
Costs and arrangements in Thailand
Obtain written confirmation of the proposed use’s status in Thailand and the responsible clinician and facility. If treatment is offered within research, ask for the study identifier, ethics oversight, participant information and contact details for the study team.
An estimate should separate consultation, testing, the cell product, administration and follow-up. Ask who pays for unexpected hospital care, and whether a deposit is refundable if you are unsuitable. Confirm travel timing only after assessment. Read the international patient guide.
Frequently asked questions
Is an IV infusion a treatment for the whole body?
An IV route is not evidence that a product treats every organ or condition. Ask for a defined clinical goal and studies that support it.
Is a higher cell count better?
A quoted cell count alone cannot show value or effectiveness. Ask how the product and proposed dose relate to the supporting clinical evidence.
Can I combine it with my current treatment?
That needs individual review by your treating clinician and the proposed treatment team. Do not change prescribed medicines without their advice.
Can I book an infusion directly?
Ask about availability and clinical assessment first. This information page does not confirm that a specific product or protocol is offered.
Ask about an assessment
Contact Thailand Stem Cell Clinic to ask about the review process, current availability and how to share relevant records. Confirm the responsible clinician, proposed treatment and follow-up arrangements before booking.
Browse all treatment guides · Understand evidence levels
Sources
- ISSCR: guide to stem cell treatments
- FDA: Ryoncil product information
- FDA: information about regenerative medicine therapies
General educational information, not an individual treatment recommendation. A clinician who knows your history should assess your options. External sources describe their own products, research and jurisdictions; they do not establish availability or authorisation at this clinic.